Peer-influenced content. Sources you trust. No registration required. This is HCN.

JAMA NetworkMyocarditis or Pericarditis Following mRNA COVID-19 Vaccination

In addition to other discoveries, the authors found that reported rates of myocarditis or pericarditis were higher after vaccination with mRNA-1273 (Moderna Spikevax) compared with BNT162b2 (Pfizer-BioNTech Comirnaty).

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form